Exosens Reports Strong Q1 2026 Results with Defense Market Growth

Exosens has announced significant revenue growth for Q1 2026, with earnings reaching €122.6 million, marking a 19.7% increase from Q1 2025. This growth is largely driven by rising demand in defense-related night vision and digital imaging solutions. The company has also seen a substantial rise in its Detection & Imaging (D&I) revenue, which grew by 44.5%.

The company’s adjusted gross margin improved by 20.1%, amounting to €63.5 million. The Amplification segment showed a 15.0% increase while D&I rose by 36.8% despite a slight margin drop. Exosens is expanding its production capacity in Europe and the U.S. to meet growing demand.

Exosens has secured a significant contract with the U.S. Army for the BiNOD program, enhancing its position in the U.S. market. The acquisition of Emberion is expected to bolster its portfolio in advanced imaging technologies. With plans for continued growth, Exosens forecasts revenues between €520 million and €540 million for 2026.